| |
|
|
| Name: |
Octagon Capital Advisors LP |
| City: |
NEW YORK |
| State: |
NY |
| Zip: |
10065 |
| |
|
|
| Achive
data |
| View
Filing Period: |
|
|
|
|
|
|
 |
Download |
|
|
| |
| |
|
Free Registration Required For Full Results
|
|
|
| Holdings
Found :
13 |
|
View All Holdings |
Currently
Viewing:
Unchanged Positions |
|
|
Page 1 of 1 |
Menu
 |
Ticker |
Company Name |
Position
Rank |
New/Closed
Postion |
Last
Close |
Value |
Shares Held |
% of
Portfolio |
Value
Change |
Change In
Shares Held |
% of Company |
Industry |
|
APLS |
Apellis Pharmaceuticals Inc |
1 |
- |
$40.61 |
$164,994,000 |
2,806,980 |
20.06% |
-3,032,000 |
0 |
2.452 |
N/A |
|
|
ALPN |
Alpine Immune Sciences Inc |
2 |
- |
$64.97 |
$49,205,000 |
1,241,300 |
5.98% |
25,546,000 |
0 |
1.894 |
N/A |
|
|
VRNA |
Verona Pharma Plc |
4 |
- |
$0.00 |
$38,117,000 |
2,369,000 |
4.63% |
-8,979,000 |
0 |
2.936 |
N/A |
|
|
CNTA |
Centessa Pharmaceuticals Plc |
8 |
- |
$0.00 |
$23,279,000 |
2,060,100 |
2.83% |
6,881,000 |
0 |
2.357 |
N/A |
|
|
ANNX |
Annexon, Inc. |
19 |
- |
$0.00 |
$14,699,000 |
2,050,000 |
1.79% |
5,392,000 |
0 |
2.381 |
N/A |
|
|
AVTE |
Aerovate Therapeutics, Inc. |
21 |
- |
$0.00 |
$11,937,000 |
403,685 |
1.45% |
2,802,000 |
0 |
1.459 |
N/A |
|
|
VRDN |
Viridian Therapeutics Ors Shs |
22 |
- |
$12.11 |
$10,856,000 |
620,000 |
1.32% |
-2,648,000 |
0 |
0.989 |
N/A |
|
|
GOSS |
Gossamer Bio Inc |
23 |
- |
$0.62 |
$10,842,000 |
9,187,883 |
1.32% |
2,458,000 |
0 |
4.076 |
N/A |
|
|
GLYC |
Glycomimetics Inc |
25 |
- |
$0.27 |
$9,000,000 |
3,000,000 |
1.09% |
1,920,000 |
0 |
6.272 |
N/A |
|
|
IMVT |
Immunovant Inc |
26 |
- |
$0.00 |
$8,830,000 |
273,289 |
1.07% |
-2,684,000 |
0 |
0.314 |
N/A |
|
|
RPHM |
Reneo Pharmaceuticals, Inc. |
41 |
- |
$1.66 |
$3,735,000 |
2,250,000 |
0.45% |
135,000 |
0 |
6.655 |
N/A |
|
|
VERU |
Veru Inc |
47 |
- |
$1.23 |
$2,660,000 |
3,800,000 |
0.32% |
-76,000 |
0 |
5.439 |
Personal Products |
|
|
RAPT |
Rapt Therapeutics, Inc. |
48 |
- |
$4.18 |
$2,622,000 |
292,000 |
0.32% |
-4,634,000 |
0 |
0.809 |
N/A |
|
